Free Trial
OTCMKTS:BETRF

BetterLife Pharma (BETRF) Stock Price, News & Analysis

BetterLife Pharma logo
$0.07
0.00 (0.00%)
(As of 10/31/2024 ET)

About BetterLife Pharma Stock (OTCMKTS:BETRF)

Key Stats

Today's Range
$0.07
$0.07
50-Day Range
$0.07
$0.14
52-Week Range
$0.03
$0.15
Volume
25 shs
Average Volume
30,077 shs
Market Capitalization
$9.02 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections. The company's products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat benzodiazepine dependency, anxiety, and neurodegenerative disorders. It is also developing MM-003, which has completed Phase II clinical trials for treatment of COVID-19 and other respiratory viral infections; and MM-001, a topical cream for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia that has completed Phase II clinical trials. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada.

BetterLife Pharma Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
25th Percentile Overall Score

BETRF MarketRank™: 

BetterLife Pharma scored higher than 25% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of BetterLife Pharma is -2.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of BetterLife Pharma is -2.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    0.00% of the outstanding shares of BetterLife Pharma have been sold short.
  • Short Interest Ratio / Days to Cover

    BetterLife Pharma has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in BetterLife Pharma has recently decreased by 80.00%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    BetterLife Pharma does not currently pay a dividend.

  • Dividend Growth

    BetterLife Pharma does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.00% of the outstanding shares of BetterLife Pharma have been sold short.
  • Short Interest Ratio / Days to Cover

    BetterLife Pharma has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in BetterLife Pharma has recently decreased by 80.00%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    BetterLife Pharma has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for BetterLife Pharma this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, BetterLife Pharma insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    34.77% of the stock of BetterLife Pharma is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 0.01% of the stock of BetterLife Pharma is held by institutions.

  • Read more about BetterLife Pharma's insider trading history.
Receive BETRF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BetterLife Pharma and its competitors with MarketBeat's FREE daily newsletter.

BETRF Stock News Headlines

BetterLife Pharma Inc BETRF
Watch this before it gets removed
If you missed it, my emergency election broadcast is now available - but will be removed soon
BetterLife Pharma Inc (BETR)
NPAU.SG,0P0001CXAU,0 (NPAU.SG)
BetterLife Announces Closing of a Private Placement
See More Headlines

BETRF Stock Analysis - Frequently Asked Questions

BetterLife Pharma's stock was trading at $0.0480 at the beginning of 2024. Since then, BETRF stock has increased by 53.5% and is now trading at $0.0737.
View the best growth stocks for 2024 here
.

BetterLife Pharma Inc. (OTCMKTS:BETRF) announced its quarterly earnings results on Wednesday, September, 25th. The company reported ($0.01) earnings per share for the quarter.

Shares of BETRF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Last Earnings
9/25/2024
Today
10/31/2024
Fiscal Year End
1/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:BETRF
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Net Income
$-2,140,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.05) per share

Miscellaneous

Free Float
84,449,000
Market Cap
$9.02 million
Optionable
Not Optionable
Beta
1.23
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

This page (OTCMKTS:BETRF) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners